University of Louvain bacteria research appeals to Japan
Launch of a joint research group Kaneka - Eurogentec - UCLouvain
18 November 2020
19 November 2020
- Kaneka and its Walloon subsidiary, Kaneka Eurogentec S.A., enter into a partnership with Pr Jean-François Collet's laboratory by funding a new joint research group at the Duve Institute of University of Louvain (UClouvain). The group will consist of up to 15 people.
- This mixed university-company group will develop optimised bacterial strains for the production of biomedicines.
- The use of biomedicines is disrupting current medicine by offering new perspectives for treating cancer, infectious diseases, diabetes and genetic illnesses.
Press Release-Kaneka - Eurogentec - UCLouvain_EN
PDF - 711 Kb
Download
Press Release-Kaneka - Eurogentec - UCLouvain_FR
PDF - 766 Kb
Download
.jpg "Kaneka Eurogentec - UCLouvain - HD (10)")
.jpg "Kaneka Eurogentec - UCLouvain - HD (1)")
.jpg "Kaneka Eurogentec - UCLouvain - HD (5)")
.jpg "Kaneka Eurogentec - UCLouvain - HD (6)")
.jpg "Kaneka Eurogentec - UCLouvain - HD (7)")
.jpg "Kaneka Eurogentec - UCLouvain - HD (8)")
.jpg "Kaneka Eurogentec - UCLouvain - HD (11)")
.jpg "Kaneka Eurogentec - UCLouvain - HD (15)")